(GIL) Gildan Activewear - Overview
Stock: T-Shirts, Fleece, Socks, Underwear, Polos
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.74% |
| Yield on Cost 5y | 3.56% |
| Yield CAGR 5y | 18.27% |
| Payout Consistency | 95.5% |
| Payout Ratio | 35.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.0% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 26.88 |
| Character TTM | |
|---|---|
| Beta | 0.952 |
| Beta Downside | 0.895 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.28% |
| CAGR/Max DD | 1.23 |
Description: GIL Gildan Activewear January 07, 2026
Gildan Activewear Inc. (NYSE:GIL) is a vertically integrated apparel manufacturer that produces a broad portfolio of activewear, casual clothing, hosiery, and underwear under its own brands-including Gildan, Champion, and American Apparel-as well as private-label contracts for lifestyle brands. Its distribution network reaches wholesale partners, screen-printers, and retailers across North America, Europe, Asia-Pacific, and Latin America, covering mass merchants, department stores, specialty shops, and e-commerce channels.
Key operating metrics that analysts watch include a 2023 revenue of $2.8 billion with a 5-year CAGR of roughly 6 % (driven by strong athleisure demand), an average gross margin of 30 % (sensitive to cotton and synthetic fiber price volatility), and inventory turnover of 4.2 times, indicating efficient supply-chain management. The company’s earnings per share have grown at an annualized 8 % rate, while its free cash flow conversion consistently exceeds 80 % of net income, supporting dividend sustainability. Primary economic drivers are consumer discretionary spending trends, the ongoing shift toward “work-from-home” and athleisure apparel, and input-cost exposure to commodity (cotton, polyester) and labor rates in low-cost manufacturing hubs.
For a deeper, data-driven look at GIL’s valuation assumptions and scenario outcomes, the ValueRay platform provides a concise analytical snapshot worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 475.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -1.19 > 1.0 |
| NWC/Revenue: 33.19% < 20% (prev 33.49%; Δ -0.30% < -1%) |
| CFO/TA 0.12 > 3% & CFO 490.3m > Net Income 475.1m |
| Net Debt (1.76b) to EBITDA (809.5m): 2.17 < 3 |
| Current Ratio: 2.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (150.8m) vs 12m ago -6.34% < -2% |
| Gross Margin: 31.85% > 18% (prev 0.30%; Δ 3155 % > 0.5%) |
| Asset Turnover: 86.17% > 50% (prev 86.52%; Δ -0.35% > 0%) |
| Interest Coverage Ratio: 5.60 > 6 (EBITDA TTM 809.5m / Interest Expense TTM 121.0m) |
Altman Z'' 4.47
| A: 0.27 (Total Current Assets 2.22b - Total Current Liabilities 1.11b) / Total Assets 4.07b |
| B: 0.28 (Retained Earnings 1.15b / Total Assets 4.07b) |
| C: 0.17 (EBIT TTM 677.9m / Avg Total Assets 3.90b) |
| D: 0.55 (Book Value of Equity 1.42b / Total Liabilities 2.58b) |
| Altman-Z'' Score: 4.47 = AA |
Beneish M -2.97
| DSRI: 1.13 (Receivables 723.1m/612.9m, Revenue 3.36b/3.23b) |
| GMI: 0.96 (GM 31.85% / 30.45%) |
| AQI: 0.93 (AQ_t 0.14 / AQ_t-1 0.15) |
| SGI: 1.04 (Revenue 3.36b / 3.23b) |
| TATA: -0.00 (NI 475.1m - CFO 490.3m) / TA 4.07b) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
What is the price of GIL shares?
Over the past week, the price has changed by +8.94%, over one month by +14.31%, over three months by +30.81% and over the past year by +45.59%.
Is GIL a buy, sell or hold?
- StrongBuy: 6
- Buy: 6
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GIL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 79.4 | 9.5% |
| Analysts Target Price | 79.4 | 9.5% |
| ValueRay Target Price | 94.2 | 29.8% |
GIL Fundamental Data Overview February 07, 2026
P/E Forward = 15.083
P/S = 3.9227
P/B = 8.4141
P/EG = 0.6631
Revenue TTM = 3.36b USD
EBIT TTM = 677.9m USD
EBITDA TTM = 809.5m USD
Long Term Debt = 1.30b USD (from longTermDebt, last quarter)
Short Term Debt = 468.6m USD (from shortTermDebt, last quarter)
Debt = 1.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.76b USD (from netDebt column, last quarter)
Enterprise Value = 14.95b USD (13.19b + Debt 1.87b - CCE 112.6m)
Interest Coverage Ratio = 5.60 (Ebit TTM 677.9m / Interest Expense TTM 121.0m)
EV/FCF = 40.15x (Enterprise Value 14.95b / FCF TTM 372.2m)
FCF Yield = 2.49% (FCF TTM 372.2m / Enterprise Value 14.95b)
FCF Margin = 11.07% (FCF TTM 372.2m / Revenue TTM 3.36b)
Net Margin = 14.13% (Net Income TTM 475.1m / Revenue TTM 3.36b)
Gross Margin = 31.85% ((Revenue TTM 3.36b - Cost of Revenue TTM 2.29b) / Revenue TTM)
Gross Margin QoQ = 33.67% (prev 31.51%)
Tobins Q-Ratio = 3.67 (Enterprise Value 14.95b / Total Assets 4.07b)
Interest Expense / Debt = 1.50% (Interest Expense 28.1m / Debt 1.87b)
Taxrate = 19.03% (28.2m / 148.4m)
NOPAT = 548.9m (EBIT 677.9m * (1 - 19.03%))
Current Ratio = 2.01 (Total Current Assets 2.22b / Total Current Liabilities 1.11b)
Debt / Equity = 1.26 (Debt 1.87b / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = 2.17 (Net Debt 1.76b / EBITDA 809.5m)
Debt / FCF = 4.72 (Net Debt 1.76b / FCF TTM 372.2m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.18% (Net Income 475.1m / Total Assets 4.07b)
RoE = 32.90% (Net Income TTM 475.1m / Total Stockholder Equity 1.44b)
RoCE = 24.67% (EBIT 677.9m / Capital Employed (Equity 1.44b + L.T.Debt 1.30b))
RoIC = 17.44% (NOPAT 548.9m / Invested Capital 3.15b)
WACC = 8.40% (E(13.19b)/V(15.06b) * Re(9.42%) + D(1.87b)/V(15.06b) * Rd(1.50%) * (1-Tc(0.19)))
Discount Rate = 9.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.31%
[DCF Debug] Terminal Value 75.18% ; FCFF base≈377.9m ; Y1≈345.6m ; Y5≈306.2m
Fair Price DCF = 18.00 (EV 5.09b - Net Debt 1.76b = Equity 3.33b / Shares 185.2m; r=8.40% [WACC]; 5y FCF grow -10.66% → 2.90% )
EPS Correlation: -18.83 | EPS CAGR: -47.50% | SUE: -4.0 | # QB: 0
Revenue Correlation: 12.74 | Revenue CAGR: 4.40% | SUE: -0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.71 | Chg30d=+0.064 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=4.52 | Chg30d=+0.004 | Revisions Net=+1 | Growth EPS=+29.5% | Growth Revenue=+98.2%